Related Experiment Videos
Medicare reimbursement for home infusion therapy: a contributor to the development of community acquired
Abstract:
Vancomycin is a bacteriocidal antibiotic widely used to treat gram-positive infections, including methicillin-resistant Staphylococcus aureus. During the past 5 years, there have been increasingly frequent reports of infections caused by enterococci species resistant to vancomycin. Until recently, this was a phenomenon limited almost exclusively to the hospital. Presently, there are reports of vancomycin-resistant enterococci developing in the outpatient and home care population. The intent of this article is to present one possible explanation for this trend in the hope that further research will be stimulated.
Insights
Vancomycin-resistant enterococci (VRE) infections are increasing, even in outpatient settings. This article explores potential reasons for this concerning trend in antibiotic resistance.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Vancomycin is a critical antibiotic for treating Gram-positive bacterial infections.
- Rising rates of vancomycin-resistant enterococci (VRE) infections are a significant public health concern.
- VRE infections are increasingly reported outside of traditional hospital settings.
Purpose of the Study:
- To explain the growing prevalence of vancomycin resistance in enterococci.
- To investigate the emergence of VRE in outpatient and home care populations.
- To stimulate further research into the drivers of antibiotic resistance.
Main Methods:
- Literature review of recent VRE infection reports.
- Analysis of trends in antibiotic resistance patterns.
- Exploration of potential contributing factors to VRE development.
Main Results:
- Vancomycin resistance in enterococci has become more frequent in the last five years.
- VRE infections are no longer confined to hospitals, appearing in community and home care settings.
- A specific explanation for this trend is proposed.
Conclusions:
- The spread of vancomycin resistance is a dynamic and evolving issue.
- Understanding the factors driving VRE in non-hospitalized patients is crucial.
- Further research is needed to address the challenge of emerging antibiotic resistance.